S. Juthong

Efficacy of Roflumilast in Bronchiectasis Patients with Frequent Exacerbations: A Double-Blinded, Randomized, Placebo-Controlled Pilot Clinical Trial

S. Juthong, P. Panyarath, 2021, Tuberculosis and respiratory diseases.

Roxithromycin as Anti-Inflammatory Drug Improves Clinical Outcomes in Adult Patients with Bronchiectasis: A Double- Blinded Randomized, Placebo-Controlled Pilot Clinical Trial

S. Juthong, Sarayuth Eiamsa-ard, 2019, Journal of Health Science and Medical Research.

Long-term effectiveness of omalizumab treatment in Thai severe asthmatic patients: A real-life experience.

W. Boonsawat, P. Pornsuriyasak, O. Poachanukoon, 2018, Asian Pacific journal of allergy and immunology.

Evaluation of Proinflammatory Cytokines and Adverse Events in Healthy Volunteers upon Inhalation of Antituberculosis Drugs.

T. Srichana, Alwar Ramanujam Padmavathi, P. Pungrassami, 2016, Biological & pharmaceutical bulletin.

Clinical equivalence of budesonide dry powder inhaler and pressurized metered dose inhaler

T. Srichana, S. Juthong, S. Soorapan, 2016, The clinical respiratory journal.

Association between blood eosinophils with exacerbation and patient-reported outcomes in chronic obstructive pulmonary disease patients in an endemic area for parasitic infections: a prospective study

S. Juthong, P. Kaenmuang, 2020, Journal of thoracic disease.

Ambroxol Lozenge Bioavailability

D. Faroongsarng, S. Kasiwong, S. Juthong, 2003, Clinical drug investigation.

Clinical manifestation and survival of patients with small-cell lung cancer.

S. Juthong, W. Tanomkiat, Warangkana Rittirak, 2004, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Clinical Concepts for Triple Therapy Use in Patients with COPD: A Delphi Consensus

M. Miravitlles, S. Acharya, J. Jardim, 2023, International journal of chronic obstructive pulmonary disease.

The burden of systemic corticosteroid use in asthma management in Asia

M. Koh, C. Rhee, D. Perng, 2023, Respirology.